No connection

Search Results

MRM

BEARISH
$1.11 Live
MEDIROM Healthcare Technologies Inc. · NASDAQ
$0.6 52W Range $4.45

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 15, 2026
Market cap
$8.77M
P/E
3.0
ROE
53.2%
Profit margin
0.5%
Debt/Equity
7.86
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
90%
MRM presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe underlying liquidity distress. While the stock trades below its Graham Number ($1.27) and Intrinsic Value ($2.59), these valuation metrics are overshadowed by a catastrophic Current Ratio of 0.24 and an extreme Debt/Equity ratio of 7.86. The company is experiencing declining revenue growth (-6.70%) and deep operating losses (-25.84% margin), suggesting that the nominal net profit is likely driven by non-operating items rather than core business health.

Key Strengths

Current price is below the Graham Number ($1.27)
Very low P/E ratio of 3.00
Positive net profit margin (0.50%)
High ROE (53.19%), though likely inflated by high leverage
Positive 1-year price performance (+15.6%)

Key Risks

Severe liquidity crisis with a Current Ratio of 0.24
Extreme leverage with Debt/Equity at 7.86
Negative operating margin of -25.84% indicating core business inefficiency
Declining year-over-year revenue growth (-6.70%)
Strongly bearish technical trend (0/100)
AI Fair Value Estimate
Based on comprehensive analysis
$1.15
+3.6% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
19
Weak
Value
50
Future
20
Past
15
Health
10
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Insolvency risk due to liquidity ratios, Extreme debt burden, Negative operating cash flow profile
Confidence
95%
Value
50/100

Ref P/E 3.00, Graham Number $1.27

Positives
  • Price < Graham Number
  • Low P/E
Watchpoints
  • High Price/Book (5.73)
  • Value metrics are misleading given the debt load
Future
20/100

Ref Revenue Growth -6.70%

Positives
No standout positives identified.
Watchpoints
  • Negative revenue growth
  • Bearish technicals
Past
15/100

Ref 5Y Change -88.0%

Positives
  • 1Y recovery
Watchpoints
  • Severe 3Y and 5Y value destruction
Health
10/100

Ref Piotroski F-Score and Liquidity Ratios

Positives
  • Piotroski F-Score 4/9 (Stable)
Watchpoints
  • Current Ratio 0.24
  • Debt/Equity 7.86
  • Quick Ratio 0.14
Dividend
0/100

Ref Dividend Strength 0/100

Positives
No standout positives identified.
Watchpoints
  • No dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.11

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MRM and closest competitors.

Updated 2026-04-14
MRM
MEDIROM Healthcare Technologies Inc.
Primary
5Y
-88.0%
3Y
-82.1%
1Y
+15.6%
6M
-48.4%
1M
-12.6%
1W
-0.9%
FMF
Kandal M Venture Limited
Peer
5Y
-89.0%
3Y
-89.0%
1Y
-89.0%
6M
-94.2%
1M
+12.6%
1W
+21.6%
INE
INNEOVA Holdings Limited
Peer
5Y
-92.2%
3Y
-92.2%
1Y
-41.9%
6M
-46.6%
1M
+1.6%
1W
-2.5%
LOB
Lobo Technologies Ltd.
Peer
5Y
-83.4%
3Y
-83.4%
1Y
-2.0%
6M
-29.3%
1M
+8.7%
1W
+25.8%
NCI
Neo-Concept International Group Holdings Limited
Peer
5Y
-98.9%
3Y
-98.9%
1Y
-74.8%
6M
-71.7%
1M
-91.8%
1W
-8.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
3.0
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
5.73
P/S Ratio
0.0
EV/Revenue
0.51
EV/EBITDA
27.83
Market Cap
$8.77M

Profitability

Profit margins and return metrics

Profit Margin 0.5%
Operating Margin -25.84%
Gross Margin 25.05%
ROE 53.19%
ROA -1.78%

Growth

Revenue and earnings growth rates

Revenue Growth -6.7%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
7.86
High debt
Current Ratio
0.24
Weak
Quick Ratio
0.14
Poor
Cash/Share
$4.13

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2024

Total Assets
$8.1B
Liabilities
$6.9B
Equity
$0.9B
Debt/Equity
7.40x

Consumer Cyclical Sector Comparison

Comparing MRM against 237 companies in the Consumer Cyclical sector (12 bullish, 83 neutral, 142 bearish)
P/E Ratio
3.0
This Stock
vs
36.19
Sector Avg
-91.7% (Discount)
Return on Equity (ROE)
53.19%
This Stock
vs
-38.9%
Sector Avg
-236.7% (Below Avg)
Profit Margin
0.5%
This Stock
vs
-4.36%
Sector Avg
-111.5% (Weaker)
Debt to Equity
7.86
This Stock
vs
1.4
Sector Avg
+461.0% (Higher)
Revenue Growth
-6.7%
This Stock
vs
16.59%
Sector Avg
-140.4% (Slower)
Current Ratio
0.24
This Stock
vs
2.5
Sector Avg
-90.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning MRM from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile